CD274 and neoplasm: MDSC formed in the pre-tumor immunosuppressive microenvironment are one of the major causes of resistance to immune checkpoint blockade (ICB) therapies, and inhibition of MDSC accumulation and function is critical for effective anti-PD-L1 immunotherapy [85].